EGF and cervical carcinoma: Since we have also observed that cyclin G2 can exert potent anti-tumorigenic effects [18], it is possible that inhibition of cyclin G2 by EGFR is a significant event underlying the oncogenic actions of EGF and contributes to ovarian and cervical cancer development.